Cargando…
Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator
BACKGROUND: Heart failure (HF) is the terminal stage of all cardiovascular events. Although implantable cardioverter defibrillator (ICD) therapies have reduced mortality among the high-risk HF population, it is necessary to determine whether certain factors can predict mortality even after cardiac d...
Autores principales: | Hou, Zhi-wei, Yu, Hai-bo, Liang, Yan-chun, Gao, Yang, Xu, Guo-qing, Wu, Min, Mei, Zhu, Wang, Zu-lu, Li, Zhi-guo, Li, Yu-ying, Song, Hai-xu, Li, Jia-yin, Han, Ya-ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685860/ https://www.ncbi.nlm.nih.gov/pubmed/33282418 http://dx.doi.org/10.1155/2020/4375651 |
Ejemplares similares
-
The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014) -
The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022) -
Implantable cardioverter-defibrillators /
Publicado: (1994) -
Causes of Failure to Capture in Pacemakers and Implantable Cardioverter-defibrillators
por: Sabbagh, Ebrahim, et al.
Publicado: (2020) -
Intraoperative defibrillation threshold testing and postoperative long-term efficacy of cardioverter-defibrillator implantation
por: GAN, TIANYI, et al.
Publicado: (2013)